Efficacy and safety of two simplified regional citrate anticoagulation protocols in intermittent hemodialysis: a randomized crossover trial

Conventional regional citrate anticoagulation (RCA) is effective for patients at high bleeding risk but operationally complex. Simplified RCA (S-RCA) uses calcium-containing dialysate and pre-dialyzer citrate infusion; citrate removal across the dialyzer may nevertheless leave the venous bubble trap insufficiently anticoagulated. We compared S-RCA with a two-stage protocol (TS-RCA) that redistributes part of the citrate dose downstream. In this single-center, open-label, randomized crossover trial, 30 adults with active bleeding or high bleeding risk underwent two 4-hour intermittent hemodialysis sessions, one with each protocol. Effective anticoagulation was defined as completing the planned session with clotting grades < 3 in both the dialyzer and venous bubble trap. Secondary outcomes included circuit survival, component-specific clotting, dialysis adequacy, biochemical changes, and adverse events. All participants completed both periods. Effective anticoagulation occurred in 26/30 TS-RCA and 19/30 S-RCA sessions (86.7% vs. 63.3%; P = 0.063). Session duration was longer with TS-RCA (3.94 ± 0.21 vs. 3.68 ± 0.60 h; mean difference 0.26 h; 95% CI, 0.03 to 0.48; P = 0.027) and venous bubble-trap clotting was less severe ( P = 0.001); dialyzer clotting and dialysis adequacy were comparable. Postdialysis systemic ionized calcium was 1.02 ± 0.11 mmol/L with TS-RCA and 1.08 ± 0.13 mmol/L with S-RCA ( P = 0.031), but the between-protocol difference in within-session change was not significant ( P = 0.054). Five hypoglycemic events occurred with each protocol, and one hypotensive event occurred with S-RCA. No serious citrate-related event was observed. TS-RCA showed a favorable but statistically nonsignificant trend toward improved effective anticoagulation versus S-RCA (86.7% vs. 63.3%; P = 0.063). These hypothesis-generating findings suggest a potentially meaningful signal and warrant larger multicenter trials with adequate power. Chinese Clinical Trial Registry, ChiCTR2000034314. Registered on 28 September‌ 2020.

Authors

Institutions

Publication Details

Journal
BMC Nephrology
Published
2026-11-16
DOI
https://doi.org/10.1186/s12882-026-05508-6
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Efficacy and safety of two simplified regional citrate anticoagulation protocols in intermittent hemodialysis: a randomized crossover trial

Qiudi Tu, Shizhu Yuan, Qiang He, Yanqing Jia et al.
1 links
BMC Nephrology
Dialysis and Renal Disease Management
article

Efficacy and safety of two simplified regional citrate anticoagulation protocols in intermittent hemodialysis: a randomized crossover trial

Qiudi Tu, Shizhu Yuan, Qiang He, Yanqing Jia, Meiling Zhou, Xiaogang Shen, Yueming Liu, Huajuan Shen
article en

Abstract

Conventional regional citrate anticoagulation (RCA) is effective for patients at high bleeding risk but operationally complex. Simplified RCA (S-RCA) uses calcium-containing dialysate and pre-dialyzer citrate infusion; citrate removal across the dialyzer may nevertheless leave the venous bubble trap insufficiently anticoagulated. We compared S-RCA with a two-stage protocol (TS-RCA) that redistributes part of the citrate dose downstream. In this single-center, open-label, randomized crossover trial, 30 adults with active bleeding or high bleeding risk underwent two 4-hour intermittent hemodialysis sessions, one with each protocol. Effective anticoagulation was defined as completing the planned session with clotting grades < 3 in both the dialyzer and venous bubble trap. Secondary outcomes included circuit survival, component-specific clotting, dialysis adequacy, biochemical changes, and adverse events. All participants completed both periods. Effective anticoagulation occurred in 26/30 TS-RCA and 19/30 S-RCA sessions (86.7% vs. 63.3%; P = 0.063). Session duration was longer with TS-RCA (3.94 ± 0.21 vs. 3.68 ± 0.60 h; mean difference 0.26 h; 95% CI, 0.03 to 0.48; P = 0.027) and venous bubble-trap clotting was less severe ( P = 0.001); dialyzer clotting and dialysis adequacy were comparable. Postdialysis systemic ionized calcium was 1.02 ± 0.11 mmol/L with TS-RCA and 1.08 ± 0.13 mmol/L with S-RCA ( P = 0.031), but the between-protocol difference in within-session change was not significant ( P = 0.054). Five hypoglycemic events occurred with each protocol, and one hypotensive event occurred with S-RCA. No serious citrate-related event was observed. TS-RCA showed a favorable but statistically nonsignificant trend toward improved effective anticoagulation versus S-RCA (86.7% vs. 63.3%; P = 0.063). These hypothesis-generating findings suggest a potentially meaningful signal and warrant larger multicenter trials with adequate power. Chinese Clinical Trial Registry, ChiCTR2000034314. Registered on 28 September‌ 2020.

BMC Nephrology
Zhejiang Chinese Medical University (CN), Affiliated Hospital of Hangzhou Normal University (CN), Zhejiang Provincial People's Hospital (CN), Shaoxing People's Hospital (CN), Hangzhou Medical College (CN)
Good health and well-being
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon